Celldex Therapeutics, Inc. (CLDX) vs Inspire Medical Systems, Inc. (INSP)

A side-by-side comparison of Celldex Therapeutics, Inc. and Inspire Medical Systems, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — CLDX vs INSP

growth of $100 · dividends reinvested · last 8y
CLDX +175.0% (+13.5%/yr)INSP +183.2% (+13.9%/yr)INSP compounded faster over this window
05001kStart $1002020202220242026$275$283
CLDX INSP

CLDX vs INSP: by the numbers

  • •CLDX is the larger company ($2.17B vs $2.05B market cap).
  • •INSP is profitable (15.03% net margin) while CLDX runs a net loss (-268385.71%).
  • •INSP grew revenue faster over the past five years (38.69% vs -58.05% CAGR).

Metrics side by side

Valuation

MetricCLDXINSP
P/E ratioN/A15.31
Forward P/EN/A59.24
P/S ratio19361.502.28
P/B ratio3.032.48
EV / EBITDAN/A27.29
FCF yieldN/A5.72%

Profitability

MetricCLDXINSP
Gross margin100.00%86.13%
Operating margin-19160.00%6.02%
Net margin-268385.71%15.03%
ROE-42.07%16.36%
ROIC-45.19%6.33%

Growth (annualized)

MetricCLDXINSP
Revenue CAGR (5Y)-58.05%38.69%
Total return CAGR (5Y)-10.28%-21.38%

Frequently asked

Which has grown faster, CLDX or INSP?
Over the past five years, INSP grew revenue faster — CLDX at a -58.05% CAGR versus INSP at 38.69%.
Is CLDX or INSP more profitable?
INSP runs the higher net margin — CLDX at -268385.71% versus INSP at 15.03%.
How have CLDX and INSP total returns compared?
Over the past 5 years, CLDX delivered -10.28% and INSP delivered -21.38% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.